This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Insulet Corporation stock | $253.04

Own Insulet Corporation stock in just a few minutes.

Posted

Fact checked

Insulet Corporation is a medical devices business based in the US. Insulet Corporation shares (PODD) are listed on the NASDAQ and all prices are listed in US Dollars. Insulet Corporation employs 1,350 staff and has a trailing 12-month revenue of around USD$825.8 million.

How to buy shares in Insulet Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Insulet Corporation. Find the stock by name or ticker symbol: PODD. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Insulet Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$253.04, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Insulet Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Insulet Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Insulet Corporation share price

Use our graph to track the performance of PODD stocks over time.

Insulet Corporation shares at a glance

Information last updated 2020-10-20.
Latest market close USD$253.04
52-week range USD$121 - USD$255.39
50-day moving average USD$229.1877
200-day moving average USD$205.5263
Wall St. target price USD$242.29
PE ratio 895.1429
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.289

Buy Insulet Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Insulet Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Insulet Corporation price performance over time

Historical closes compared with the close of $253.04 from 2020-11-16

1 week (2020-11-25) N/A
1 month (2020-11-06) -1.54%
3 months (2020-09-02) N/A
6 months (2020-06-02) N/A
1 year (2019-12-02) N/A
2 years (2018-12-02) N/A
3 years (2017-12-02) N/A
5 years (2015-12-02) N/A

Is Insulet Corporation under- or over-valued?

Valuing Insulet Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Insulet Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Insulet Corporation's P/E ratio

Insulet Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 895x. In other words, Insulet Corporation shares trade at around 895x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Insulet Corporation's PEG ratio

Insulet Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5889. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Insulet Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Insulet Corporation's EBITDA

Insulet Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$105.8 million.

The EBITDA is a measure of a Insulet Corporation's overall financial performance and is widely used to measure a its profitability.

Insulet Corporation financials

Revenue TTM USD$825.8 million
Operating margin TTM 8.49%
Gross profit TTM USD$480.3 million
Return on assets TTM 3.36%
Return on equity TTM 4.45%
Profit margin 2.19%
Book value $8.586
Market capitalisation USD$16.1 billion

TTM: trailing 12 months

Shorting Insulet Corporation shares

There are currently 2.4 million Insulet Corporation shares held short by investors – that's known as Insulet Corporation's "short interest". This figure is 14.8% down from 2.9 million last month.

There are a few different ways that this level of interest in shorting Insulet Corporation shares can be evaluated.

Insulet Corporation's "short interest ratio" (SIR)

Insulet Corporation's "short interest ratio" (SIR) is the quantity of Insulet Corporation shares currently shorted divided by the average quantity of Insulet Corporation shares traded daily (recently around 443709.09090909). Insulet Corporation's SIR currently stands at 5.5. In other words for every 100,000 Insulet Corporation shares traded daily on the market, roughly 5500 shares are currently held short.

However Insulet Corporation's short interest can also be evaluated against the total number of Insulet Corporation shares, or, against the total number of tradable Insulet Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Insulet Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Insulet Corporation shares in existence, roughly 40 shares are currently held short) or 0.0494% of the tradable shares (for every 100,000 tradable Insulet Corporation shares, roughly 49 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Insulet Corporation.

Find out more about how you can short Insulet Corporation stock.

Insulet Corporation share dividends

We're not expecting Insulet Corporation to pay a dividend over the next 12 months.

Insulet Corporation share price volatility

Over the last 12 months, Insulet Corporation's shares have ranged in value from as little as $121 up to $255.39. A popular way to gauge a stock's volatility is its "beta".

PODD.US volatility(beta: 0.72)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insulet Corporation's is 0.722. This would suggest that Insulet Corporation's shares are less volatile than average (for this exchange).

Insulet Corporation overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System comprise two devices: a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, and its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site